Page last updated: 2024-10-31

molsidomine and Acute Myelogenous Leukemia

molsidomine has been researched along with Acute Myelogenous Leukemia in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, Y1
Du, KM1
Xue, ZH1
Yan, H1
Li, D1
Liu, W1
Chen, Z1
Zhao, Q1
Tong, JH1
Zhu, YS1
Chen, GQ1

Other Studies

1 other study available for molsidomine and Acute Myelogenous Leukemia

ArticleYear
Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha.
    Leukemia, 2003, Volume: 17, Issue:11

    Topics: Antigens, CD; Cell Differentiation; Cell Division; Cell Hypoxia; Cobalt; Humans; Hypoxia-Inducible F

2003